- Home
- LRMR vs MTLS Comparison
LRMR vs MTLS Comparison
Compare LRMR & MTLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LRMR
- MTLS
- Stock Information
- Founded
- LRMR N/A
- MTLS 1990
- Country
- LRMR United States
- MTLS Belgium
- Employees
- LRMR N/A
- MTLS 2437
- Industry
- LRMR Biotechnology: Pharmaceutical Preparations
- MTLS Computer Software: Prepackaged Software
- Sector
- LRMR Health Care
- MTLS Technology
- Exchange
- LRMR Nasdaq
- MTLS Nasdaq
- Market Cap
- LRMR 426.9M
- MTLS 467.2M
- IPO Year
- LRMR N/A
- MTLS 2014
- Fundamental
- Price
- LRMR $4.02
- MTLS $7.71
- Analyst Decision
- LRMR Strong Buy
- MTLS Buy
- Analyst Count
- LRMR 8
- MTLS 1
- Target Price
- LRMR $19.63
- MTLS $9.50
- AVG Volume (30 Days)
- LRMR 1.0M
- MTLS 197.3K
- Earning Date
- LRMR 10-30-2024
- MTLS 10-24-2024
- Dividend Yield
- LRMR N/A
- MTLS N/A
- EPS Growth
- LRMR N/A
- MTLS 323.01
- EPS
- LRMR N/A
- MTLS 0.19
- Revenue
- LRMR N/A
- MTLS $297,100,156.00
- Revenue This Year
- LRMR N/A
- MTLS $8.48
- Revenue Next Year
- LRMR N/A
- MTLS $9.65
- P/E Ratio
- LRMR N/A
- MTLS $42.17
- Revenue Growth
- LRMR N/A
- MTLS 5.07
- 52 Week Low
- LRMR $3.01
- MTLS $4.70
- 52 Week High
- LRMR $13.68
- MTLS $8.50
- Technical
- Relative Strength Index (RSI)
- LRMR 26.41
- MTLS 60.40
- Support Level
- LRMR $3.01
- MTLS $7.70
- Resistance Level
- LRMR $6.91
- MTLS $8.49
- Average True Range (ATR)
- LRMR 0.55
- MTLS 0.38
- MACD
- LRMR -0.19
- MTLS -0.04
- Stochastic Oscillator
- LRMR 31.28
- MTLS 60.83
About LRMR Larimar Therapeutics Inc.
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using novel cell-penetrating peptide technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.
About MTLS Materialise NV
Materialise NV is a provider of 3D printing services. The products and services of the group are organized in three segments: Medical segment, which develops and delivers medical software solutions, medical devices, and other related products and services; Software segment, which develops and delivers additive manufacturing software solutions and related services; and Manufacturing segment, which delivers 3D printed products and related services. Its geographical segments are the United States, the Americas (excluding the USA), Belgium, Germany, Poland, France, Switzerland, the United Kingdom, Italy, the Netherlands, Other Europe, and the Asia Pacific.